Methods for treating conditions or disorders which can be alleviated by reducing food intake are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that affect satiety. The methods are useful for treating conditions or disorders, including obesity, Type II diabetes, eating disorders, and insulin-resistance syndrome. The methods are also useful for lowering the plasma glucose level, lowering the plasma lipid level, reducing the cardiac risk, reducing the appetite, and reducing the weight of subjects. Pharmaceutical compositions for use in the methods of the invention are also disclosed.

 
Web www.patentalert.com

< Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability

< Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain

> Iron chelator delivery system

> Colorectal neoplasia prophylaxis

~ 00291